Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jul;50(7):2557-9.
doi: 10.1128/AAC.00207-06.

Effect of cell culture conditions on the anticytomegalovirus activity of maribavir

Affiliations

Effect of cell culture conditions on the anticytomegalovirus activity of maribavir

Sunwen Chou et al. Antimicrob Agents Chemother. 2006 Jul.

Abstract

The cytomegalovirus UL97 kinase inhibitor maribavir suppressed viral growth more effectively in lung fibroblasts than in skin fibroblasts, and some cellular kinase inhibitors enhanced its antiviral activity. These effects influence the phenotypic assay of drug susceptibility and suggest the possibility of therapeutically useful combinations of maribavir and cellular kinase inhibitors.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
SEAP growth curves for CMV strain T2233 under different MBV concentrations in (A) HEL cells and (B) HFF. Data points are the means ± standard errors of the means from at least four assays. RLU, relative light units.
FIG. 2.
FIG. 2.
SEAP yield reduction curves of CMV strain T2233 at 5.5 days under MBV. The effects of various concentrations of MBV were tested with four different cell types (HFF, MRHF, MRC-5, and HEL cells) and with HFF in the presence of rapamycin (Rapa), roscovitine (Rosco), or the leflunomide metabolite A77-1726 (A77). One hundred percent SEAP activity is defined as the level of activity in the wells without added drug. Data points are means ± standard errors of the means from at least four assays.

Similar articles

Cited by

References

    1. Biron, K. K., R. J. Harvey, S. C. Chamberlain, S. S. Good, A. A. Smith III, M. G. Davis, C. L. Talarico, W. H. Miller, R. Ferris, R. E. Dornsife, S. C. Stanat, J. C. Drach, L. B. Townsend, and G. W. Koszalka. 2002. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole l-riboside with a unique mode of action. Antimicrob. Agents Chemother. 46:2365-2372. - PMC - PubMed
    1. Bresnahan, W. A., I. Boldogh, P. Chi, E. A. Thompson, and T. Albrecht. 1997. Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231:239-247. - PubMed
    1. Chou, S., L. C. Van Wechel, H. M. Lichy, and G. I. Marousek. 2005. Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene. Antimicrob. Agents Chemother. 49:2710-2715. - PMC - PubMed
    1. Johnson, R. A., X. Wang, X. L. Ma, S. M. Huong, and E. S. Huang. 2001. Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J. Virol. 75:6022-6032. - PMC - PubMed
    1. Kudchodkar, S. B., Y. Yu, T. G. Maguire, and J. C. Alwine. 2004. Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase. J. Virol. 78:11030-11039. - PMC - PubMed

Publication types

LinkOut - more resources